BIOQUAL, Inc. BIOQ
OTC PK
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -18.25% | -13.57% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -18.25% | -13.57% | -- | -- | -- |
| Cost of Revenue | -15.44% | -18.01% | -- | -- | -- |
| Gross Profit | -30.47% | 12.22% | -- | -- | -- |
| SG&A Expenses | -1.90% | -5.49% | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -12.50% | -15.41% | -- | -- | -- |
| Operating Income | -135.81% | 39.29% | -- | -- | -- |
| Income Before Tax | -188.82% | 50.58% | -- | -- | -- |
| Income Tax Expenses | 289.81% | 69.01% | -- | -- | -- |
| Earnings from Continuing Operations | -297.68% | 41.93% | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -297.68% | 41.93% | -- | -- | -- |
| EBIT | -135.81% | 39.29% | -- | -- | -- |
| EBITDA | -575.47% | 96.97% | -- | -- | -- |
| EPS Basic | -297.70% | 41.92% | -- | -- | -- |
| Normalized Basic EPS | -188.89% | 50.57% | -- | -- | -- |
| EPS Diluted | -294.16% | 42.14% | -- | -- | -- |
| Normalized Diluted EPS | -188.89% | 50.57% | -- | -- | -- |
| Average Basic Shares Outstanding | 0.00% | 0.00% | -- | -- | -- |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | -- | -- | -- |
| Dividend Per Share | -- | 0.00% | -- | -- | -- |
| Payout Ratio | -- | 1.00% | -- | -- | -- |